Including pregnant and breastfeeding people in trials of novel LAED PrEP agents: perspectives from sub‐Saharan Africa community stakeholders

Prior to the implementation of protocol changes, HPTN 084 community working group members hosted a stakeholder consultation to gather community perspectives on proposed pregnancy-related amendments, including relaxation of contraceptive requirements and active CAB dosing during pregnancy and lactati...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the International AIDS Society 2023-07, Vol.26 (S2), p.e26120-n/a
Main Authors: White, Rhonda R., Dyer, Molly C., Hosseinipour, Mina C., Delany‐Moretlwe, Sinead
Format: Article
Language:English
Subjects:
Acquired immune deficiency syndrome
AIDS
Allergies
Breast Feeding
Breast milk
Breastfeeding & lactation
Clinical trials
Data management
Drug abuse
Female
Funding
Health aspects
HIV
HIV infection
HIV Infections - drug therapy
HIV Infections - prevention & control
Human immunodeficiency virus
Humans
Infectious diseases
Management
Pharmacology
Pregnancy
Pregnant women
Prevention
Social aspects
Stakeholders
Viewpoint
Womens health
Working groups
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c6510-d1305c568fdcf5f73637d83ff446793004fcb9e4897c431b8a6a80869d30fbeb3
cites cdi_FETCH-LOGICAL-c6510-d1305c568fdcf5f73637d83ff446793004fcb9e4897c431b8a6a80869d30fbeb3
container_end_page n/a
container_issue S2
container_start_page e26120
container_title Journal of the International AIDS Society
container_volume 26
creator White, Rhonda R.
Dyer, Molly C.
Hosseinipour, Mina C.
Delany‐Moretlwe, Sinead
description Prior to the implementation of protocol changes, HPTN 084 community working group members hosted a stakeholder consultation to gather community perspectives on proposed pregnancy-related amendments, including relaxation of contraceptive requirements and active CAB dosing during pregnancy and lactation. While qualitative in nature, the Zoom polls confirmed that the greatest concerns related to CAB safety during pregnancy (as opposed to lactation despite virtually no available data on CAB in breast milk), and that partners were likely to be extremely influential in participants’ decisions to use CAB in pregnancy. FUNDING This study was made possible through funding support from the National Institute of Allergy and Infectious Diseases, Office of the Director (NIAID), National Institutes of Health (NIH), Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD), National Institute on Drug Abuse (NIDA), and the National Institute of Mental Health (NIMH), under award numbers UM1AI068619 (HPTN Leadership and Operations Center), UM1AI068617 (HPTN Statistical and Data Management Center), and UM1AI068613 (HPTN Laboratory Center).
doi_str_mv 10.1002/jia2.26120
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_3debcca840544209b30516967da4f422</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A792906333</galeid><doaj_id>oai_doaj_org_article_3debcca840544209b30516967da4f422</doaj_id><sourcerecordid>A792906333</sourcerecordid><originalsourceid>FETCH-LOGICAL-c6510-d1305c568fdcf5f73637d83ff446793004fcb9e4897c431b8a6a80869d30fbeb3</originalsourceid><addsrcrecordid>eNp9kl-r0zAUwIso3uv0xQ8gAUFE2MyfNm3vi4zr1MnAC-pzSNOTLbNNZtJO7pufQPyMfhKz9XrdZNgWWpLf-Z30nJMkjwmeEIzpy7WRdEI5ofhOck7yrBhTntG7B99nyYMQ1hhzWqTl_eSM5SkrMc_Pkx9zq5q-NnaJNh6WVtoOSVujyoMMnQYYtsBtGkDGos4b2QTkNLJuCw1aTGev0ZWfXSG5BNuFi8j6sAHVmS0EpL1rUeirX99_fpQr6aVFU-2Nkki5tu2t6a5R6OQXWLmmjoEPk3s6-uHRzXuUfH4z-3T5brz48HZ-OV2MFc8IHteE4UxlvNC10pnOGWd5XTCt05TnJcM41aoqIS3KXKWMVIXkssAFL2uGdQUVGyXzwVs7uRYbb1rpr4WTRuwXnF8K6TujGhCshkopWaQ4S1OKyyqmJrzkeS1TnVIaXa8G16avWqhVLIOXzZH0eMealVi6rSCYxS7gneH5jcG7rz2ETrQmKGgaacH1QdCC8SLP2T7Z03_Qteu9jbXaU6Qk8flLLWX8A2O1i4nVTiqmeUlj61m8Rsn4BBXbCPGUzoI2cfmIn5zg411Da9TJgGcHASuQTbcKruk742w4Bl8MoPIuBA_6tnoEi92Mi92Mi_2MR_jJYb1v0T9DHQEyAN_iea7_oxLv51M6SH8DJaIFfQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2836191191</pqid></control><display><type>article</type><title>Including pregnant and breastfeeding people in trials of novel LAED PrEP agents: perspectives from sub‐Saharan Africa community stakeholders</title><source>Wiley-Blackwell Open Access Collection</source><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>White, Rhonda R. ; Dyer, Molly C. ; Hosseinipour, Mina C. ; Delany‐Moretlwe, Sinead</creator><creatorcontrib>White, Rhonda R. ; Dyer, Molly C. ; Hosseinipour, Mina C. ; Delany‐Moretlwe, Sinead</creatorcontrib><description>Prior to the implementation of protocol changes, HPTN 084 community working group members hosted a stakeholder consultation to gather community perspectives on proposed pregnancy-related amendments, including relaxation of contraceptive requirements and active CAB dosing during pregnancy and lactation. While qualitative in nature, the Zoom polls confirmed that the greatest concerns related to CAB safety during pregnancy (as opposed to lactation despite virtually no available data on CAB in breast milk), and that partners were likely to be extremely influential in participants’ decisions to use CAB in pregnancy. FUNDING This study was made possible through funding support from the National Institute of Allergy and Infectious Diseases, Office of the Director (NIAID), National Institutes of Health (NIH), Eunice Kennedy Shriver National Institute of Child Health &amp; Human Development (NICHD), National Institute on Drug Abuse (NIDA), and the National Institute of Mental Health (NIMH), under award numbers UM1AI068619 (HPTN Leadership and Operations Center), UM1AI068617 (HPTN Statistical and Data Management Center), and UM1AI068613 (HPTN Laboratory Center).</description><identifier>ISSN: 1758-2652</identifier><identifier>EISSN: 1758-2652</identifier><identifier>DOI: 10.1002/jia2.26120</identifier><identifier>PMID: 37439067</identifier><language>eng</language><publisher>Switzerland: John Wiley &amp; Sons, Inc</publisher><subject>Acquired immune deficiency syndrome ; AIDS ; Allergies ; Breast Feeding ; Breast milk ; Breastfeeding &amp; lactation ; Clinical trials ; Data management ; Drug abuse ; Female ; Funding ; Health aspects ; HIV ; HIV infection ; HIV Infections - drug therapy ; HIV Infections - prevention &amp; control ; Human immunodeficiency virus ; Humans ; Infectious diseases ; Management ; Pharmacology ; Pregnancy ; Pregnant women ; Prevention ; Social aspects ; Stakeholders ; Viewpoint ; Womens health ; Working groups</subject><ispartof>Journal of the International AIDS Society, 2023-07, Vol.26 (S2), p.e26120-n/a</ispartof><rights>2023 The Authors. published by John Wiley &amp; Sons Ltd on behalf of the International AIDS Society.</rights><rights>COPYRIGHT 2023 John Wiley &amp; Sons, Inc.</rights><rights>2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c6510-d1305c568fdcf5f73637d83ff446793004fcb9e4897c431b8a6a80869d30fbeb3</citedby><cites>FETCH-LOGICAL-c6510-d1305c568fdcf5f73637d83ff446793004fcb9e4897c431b8a6a80869d30fbeb3</cites><orcidid>0000-0002-0036-5144 ; 0000-0003-2174-313X ; 0000-0003-0376-1019</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2836191191/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2836191191?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,11542,25732,27903,27904,36991,36992,44569,46031,46455,53770,53772,74873</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37439067$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>White, Rhonda R.</creatorcontrib><creatorcontrib>Dyer, Molly C.</creatorcontrib><creatorcontrib>Hosseinipour, Mina C.</creatorcontrib><creatorcontrib>Delany‐Moretlwe, Sinead</creatorcontrib><title>Including pregnant and breastfeeding people in trials of novel LAED PrEP agents: perspectives from sub‐Saharan Africa community stakeholders</title><title>Journal of the International AIDS Society</title><addtitle>J Int AIDS Soc</addtitle><description>Prior to the implementation of protocol changes, HPTN 084 community working group members hosted a stakeholder consultation to gather community perspectives on proposed pregnancy-related amendments, including relaxation of contraceptive requirements and active CAB dosing during pregnancy and lactation. While qualitative in nature, the Zoom polls confirmed that the greatest concerns related to CAB safety during pregnancy (as opposed to lactation despite virtually no available data on CAB in breast milk), and that partners were likely to be extremely influential in participants’ decisions to use CAB in pregnancy. FUNDING This study was made possible through funding support from the National Institute of Allergy and Infectious Diseases, Office of the Director (NIAID), National Institutes of Health (NIH), Eunice Kennedy Shriver National Institute of Child Health &amp; Human Development (NICHD), National Institute on Drug Abuse (NIDA), and the National Institute of Mental Health (NIMH), under award numbers UM1AI068619 (HPTN Leadership and Operations Center), UM1AI068617 (HPTN Statistical and Data Management Center), and UM1AI068613 (HPTN Laboratory Center).</description><subject>Acquired immune deficiency syndrome</subject><subject>AIDS</subject><subject>Allergies</subject><subject>Breast Feeding</subject><subject>Breast milk</subject><subject>Breastfeeding &amp; lactation</subject><subject>Clinical trials</subject><subject>Data management</subject><subject>Drug abuse</subject><subject>Female</subject><subject>Funding</subject><subject>Health aspects</subject><subject>HIV</subject><subject>HIV infection</subject><subject>HIV Infections - drug therapy</subject><subject>HIV Infections - prevention &amp; control</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Infectious diseases</subject><subject>Management</subject><subject>Pharmacology</subject><subject>Pregnancy</subject><subject>Pregnant women</subject><subject>Prevention</subject><subject>Social aspects</subject><subject>Stakeholders</subject><subject>Viewpoint</subject><subject>Womens health</subject><subject>Working groups</subject><issn>1758-2652</issn><issn>1758-2652</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp9kl-r0zAUwIso3uv0xQ8gAUFE2MyfNm3vi4zr1MnAC-pzSNOTLbNNZtJO7pufQPyMfhKz9XrdZNgWWpLf-Z30nJMkjwmeEIzpy7WRdEI5ofhOck7yrBhTntG7B99nyYMQ1hhzWqTl_eSM5SkrMc_Pkx9zq5q-NnaJNh6WVtoOSVujyoMMnQYYtsBtGkDGos4b2QTkNLJuCw1aTGev0ZWfXSG5BNuFi8j6sAHVmS0EpL1rUeirX99_fpQr6aVFU-2Nkki5tu2t6a5R6OQXWLmmjoEPk3s6-uHRzXuUfH4z-3T5brz48HZ-OV2MFc8IHteE4UxlvNC10pnOGWd5XTCt05TnJcM41aoqIS3KXKWMVIXkssAFL2uGdQUVGyXzwVs7uRYbb1rpr4WTRuwXnF8K6TujGhCshkopWaQ4S1OKyyqmJrzkeS1TnVIaXa8G16avWqhVLIOXzZH0eMealVi6rSCYxS7gneH5jcG7rz2ETrQmKGgaacH1QdCC8SLP2T7Z03_Qteu9jbXaU6Qk8flLLWX8A2O1i4nVTiqmeUlj61m8Rsn4BBXbCPGUzoI2cfmIn5zg411Da9TJgGcHASuQTbcKruk742w4Bl8MoPIuBA_6tnoEi92Mi92Mi_2MR_jJYb1v0T9DHQEyAN_iea7_oxLv51M6SH8DJaIFfQ</recordid><startdate>202307</startdate><enddate>202307</enddate><creator>White, Rhonda R.</creator><creator>Dyer, Molly C.</creator><creator>Hosseinipour, Mina C.</creator><creator>Delany‐Moretlwe, Sinead</creator><general>John Wiley &amp; Sons, Inc</general><general>John Wiley and Sons Inc</general><general>Wiley</general><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-0036-5144</orcidid><orcidid>https://orcid.org/0000-0003-2174-313X</orcidid><orcidid>https://orcid.org/0000-0003-0376-1019</orcidid></search><sort><creationdate>202307</creationdate><title>Including pregnant and breastfeeding people in trials of novel LAED PrEP agents: perspectives from sub‐Saharan Africa community stakeholders</title><author>White, Rhonda R. ; Dyer, Molly C. ; Hosseinipour, Mina C. ; Delany‐Moretlwe, Sinead</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c6510-d1305c568fdcf5f73637d83ff446793004fcb9e4897c431b8a6a80869d30fbeb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Acquired immune deficiency syndrome</topic><topic>AIDS</topic><topic>Allergies</topic><topic>Breast Feeding</topic><topic>Breast milk</topic><topic>Breastfeeding &amp; lactation</topic><topic>Clinical trials</topic><topic>Data management</topic><topic>Drug abuse</topic><topic>Female</topic><topic>Funding</topic><topic>Health aspects</topic><topic>HIV</topic><topic>HIV infection</topic><topic>HIV Infections - drug therapy</topic><topic>HIV Infections - prevention &amp; control</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Infectious diseases</topic><topic>Management</topic><topic>Pharmacology</topic><topic>Pregnancy</topic><topic>Pregnant women</topic><topic>Prevention</topic><topic>Social aspects</topic><topic>Stakeholders</topic><topic>Viewpoint</topic><topic>Womens health</topic><topic>Working groups</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>White, Rhonda R.</creatorcontrib><creatorcontrib>Dyer, Molly C.</creatorcontrib><creatorcontrib>Hosseinipour, Mina C.</creatorcontrib><creatorcontrib>Delany‐Moretlwe, Sinead</creatorcontrib><collection>Wiley-Blackwell Open Access Collection</collection><collection>Wiley Online Library Free Content</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Journal of the International AIDS Society</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>White, Rhonda R.</au><au>Dyer, Molly C.</au><au>Hosseinipour, Mina C.</au><au>Delany‐Moretlwe, Sinead</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Including pregnant and breastfeeding people in trials of novel LAED PrEP agents: perspectives from sub‐Saharan Africa community stakeholders</atitle><jtitle>Journal of the International AIDS Society</jtitle><addtitle>J Int AIDS Soc</addtitle><date>2023-07</date><risdate>2023</risdate><volume>26</volume><issue>S2</issue><spage>e26120</spage><epage>n/a</epage><pages>e26120-n/a</pages><issn>1758-2652</issn><eissn>1758-2652</eissn><abstract>Prior to the implementation of protocol changes, HPTN 084 community working group members hosted a stakeholder consultation to gather community perspectives on proposed pregnancy-related amendments, including relaxation of contraceptive requirements and active CAB dosing during pregnancy and lactation. While qualitative in nature, the Zoom polls confirmed that the greatest concerns related to CAB safety during pregnancy (as opposed to lactation despite virtually no available data on CAB in breast milk), and that partners were likely to be extremely influential in participants’ decisions to use CAB in pregnancy. FUNDING This study was made possible through funding support from the National Institute of Allergy and Infectious Diseases, Office of the Director (NIAID), National Institutes of Health (NIH), Eunice Kennedy Shriver National Institute of Child Health &amp; Human Development (NICHD), National Institute on Drug Abuse (NIDA), and the National Institute of Mental Health (NIMH), under award numbers UM1AI068619 (HPTN Leadership and Operations Center), UM1AI068617 (HPTN Statistical and Data Management Center), and UM1AI068613 (HPTN Laboratory Center).</abstract><cop>Switzerland</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>37439067</pmid><doi>10.1002/jia2.26120</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0002-0036-5144</orcidid><orcidid>https://orcid.org/0000-0003-2174-313X</orcidid><orcidid>https://orcid.org/0000-0003-0376-1019</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1758-2652
ispartof Journal of the International AIDS Society, 2023-07, Vol.26 (S2), p.e26120-n/a
issn 1758-2652
1758-2652
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_3debcca840544209b30516967da4f422
source Wiley-Blackwell Open Access Collection; Publicly Available Content Database; PubMed Central
subjects Acquired immune deficiency syndrome
AIDS
Allergies
Breast Feeding
Breast milk
Breastfeeding & lactation
Clinical trials
Data management
Drug abuse
Female
Funding
Health aspects
HIV
HIV infection
HIV Infections - drug therapy
HIV Infections - prevention & control
Human immunodeficiency virus
Humans
Infectious diseases
Management
Pharmacology
Pregnancy
Pregnant women
Prevention
Social aspects
Stakeholders
Viewpoint
Womens health
Working groups
title Including pregnant and breastfeeding people in trials of novel LAED PrEP agents: perspectives from sub‐Saharan Africa community stakeholders
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T22%3A46%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Including%20pregnant%20and%20breastfeeding%20people%20in%20trials%20of%20novel%20LAED%20PrEP%20agents:%20perspectives%20from%20sub%E2%80%90Saharan%20Africa%20community%20stakeholders&rft.jtitle=Journal%20of%20the%20International%20AIDS%20Society&rft.au=White,%20Rhonda%20R.&rft.date=2023-07&rft.volume=26&rft.issue=S2&rft.spage=e26120&rft.epage=n/a&rft.pages=e26120-n/a&rft.issn=1758-2652&rft.eissn=1758-2652&rft_id=info:doi/10.1002/jia2.26120&rft_dat=%3Cgale_doaj_%3EA792906333%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c6510-d1305c568fdcf5f73637d83ff446793004fcb9e4897c431b8a6a80869d30fbeb3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2836191191&rft_id=info:pmid/37439067&rft_galeid=A792906333&rfr_iscdi=true